Who
In numbers
- Trades disclosed
- 20
- Buys
- 2
- Sells
- 0
- Bought
- $6,945
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 21 Oct 2022
- Last trade
- 1 Jul 2026
- Last filed
- 2 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 2 Jul 2026 | KPRX Kiora PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $2,423911 at $2.66 | filing |
| 1 Jul 2026filed 2 Jul 2026 | KPRX Kiora PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $2,423911 at $2.66 | filing |
| 1 Apr 2026filed 2 Apr 2026 | KPRX Kiora PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $1,812929 at $1.95 | filing |
| 1 Apr 2026filed 2 Apr 2026 | KPRX Kiora PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $1,812929 at $1.95 | filing |
| 6 Mar 2026filed 10 Mar 2026 | KPRX Kiora PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —6,533 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | KPRX Kiora Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,067 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | KPRX Kiora Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,067 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | KPRX Kiora PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —6,533 at $0.00 | filing |
| 1 Apr 2025filed 2 Apr 2025 | KPRX Kiora Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,543 at $0.00 | filing |
| 1 Apr 2025filed 2 Apr 2025 | KPRX Kiora PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —7,772 at $0.00 | filing |
| 14 Aug 2024filed 15 Aug 2024 | KPRX Kiora PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $6,4202,000 at $3.21 | filing |
| 1 Jul 2024filed 3 Jul 2024 | KPRX Kiora Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,239 at $0.00 | filing |
| 1 Jul 2024filed 3 Jul 2024 | KPRX Kiora PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —7,620 at $0.00 | filing |
| 14 Jun 2024filed 14 Jun 2024 | KPRX Kiora PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $525100 at $5.25 | filing |
| 29 Sep 2023filed 3 Oct 2023 | KPRX Kiora Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 29 Sep 2023filed 3 Oct 2023 | KPRX Kiora PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 3 Mar 2023filed 7 Mar 2023 | KPRX Kiora Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,600 at $0.00 | filing |
| 3 Mar 2023filed 7 Mar 2023 | KPRX Kiora PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —2,400 at $0.00 | filing |
| 21 Oct 2022filed 25 Oct 2022 | KPRX Kiora Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 21 Oct 2022filed 25 Oct 2022 | KPRX Kiora PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —2,500 at $0.00 | filing |
News
Supernus Pharmaceuticals (NASDAQ:SUPN) vs. Kiora Pharmaceuticals (NASDAQ:KPRX) Critical SurveyKPRX · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name Melissa Tosca; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.